Benjamin W. Bobo, Mba Email & Phone Number

United States

United States

Las Vegas, Nevada, Us

Privately funded start-up focused on a non-invasive brain temperature measurement device. Rendered expertise in business strategy development and implementation, VC capital fundraising, product development, and market commercialization for technology with the market potential of $2.2B.Significantly advanced product development and realization of regulatory strategy languishing since 2013 due to previous inability to gain Institutional Review Board (IRB) study approval. Secured IRB clinical study site within 4 months of hire resulting in IRB approval to collect and analyze data with 5 patients enrolled.Established development process design controls and a rigorous quality management system (QMS) to ensure technology design and development are focused on patient safety and optimal outcomes.Devised regulatory strategy enabling traditional 510(k) submission vs. De Novo 510(k) via the discovery of predicate device, paving the way for accelerated product approval and commercialization.Engineered solid foundation on which to raise capital. Orchestrated production of detailed commercialization project plan (with timelines and budgets), operations plan (with financials), and projected sales forecast (spanning 3 years). Subsequently, authored corporate business plan and investor’s presentation critical to raising capital.

CCO, 2014 to 2016CEO, 2012 to 2014General Manager, 2010 to 2012VP , 2003 to 2010As a pioneering leader, I co-founded a venture capital-funded start-up developing a next generation medical device that provides intracranial pressure (ICP) monitoring in the brain and access to the brain for monitoring probes. I positioned the company as a visionary leader among KOLs and the scientific community, helmed all commercial (S&M) and product development (R&D) activities, and navigated this early commercial entity to a successful launch into the marketplace. We started the company from virtually nothing and assembled a highly motivated, focused team that took a proprietary neurological sensing technology to market and created a new category of ICP monitoring and access medical devices. I devised and executed product commercialization, hybrid sales channel, and capitalization strategies, and closed on $10 million in Series A funding in early 2014. We have overcame steep hurdles (funding, design, regulatory approval, etc.) to create value around a disruptive technology poised to become the gold standard of care in the clinical marketplace.

Randolph Afb, Tx, Us

Mba

Bachelor Of Science, Economics, Aero Space

Bachelor'S Degree, Economics